Insider · CIK 0001753231
Joris Wilms
Files at YMAB (Y-mAbs Therapeutics, Inc.). First filing Aug 27, 2024, latest Aug 27, 2024.
In brief
Joris Wilms files SEC Form 4 as COO at YMAB (Y-mAbs Therapeutics, Inc.). Since Aug 27, 2024, Joris Wilms has reported 0 open-market buys worth $0 and 1 open-market sell worth $73k, the latest filed on Aug 27, 2024.
A track record needs three past buys with six months of prices behind them; Joris Wilms has 0, so none is measured yet.
The newest scored trade: sold $73k of YMAB on Aug 26, 2024, filed Aug 27, 2024, scored 41 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Y-mAbs Therapeutics, Inc. | $73k 5,000 shares | -14% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 26, 2024 | YMAB Y-mAbs Therapeutics, Inc. | 5,000 0.01% of outstanding | $73k | Aug 26, 2024 | none |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | UTender of shares Common Stock | -12,799 | $8.60 | $110k | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Common Stock | -39,301 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -32,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -35,700 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -32,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -35,700 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -42,900 | - | - | 0 | Sep 18, 2025 |
| Aug 26, 2024 | YMAB Y-mAbs Therapeutics, Inc. | SOpen-market sale Common Stock | -5,000 | $14.69 | $73k | 30,600 | Aug 27, 2024 |
| Jan 18, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Common Stock | +17,800 | $0.00 | $0 | 35,600 | Jan 22, 2024 |
| Jan 18, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +35,700 | $0.00 | $0 | 35,700 | Jan 22, 2024 |
Questions about Joris Wilms
Answered from the filings on this page, as of the latest one.
Is Joris Wilms buying or selling?
Not in the last 12 months. Joris Wilms's latest open-market trade on SEC Form 4 was sold $73k of YMAB on Aug 26, 2024.
How did Joris Wilms's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joris Wilms has 0.
Where does Joris Wilms file Form 4?
Joris Wilms has filed Form 4 at YMAB (Y-mAbs Therapeutics, Inc.) as SVP & CHIEF OPERATING OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.